25D-NBOMe (or NBOMe-2C-D) is a derivative of the phenethylamine derived hallucinogen 2C-D. It acts in a similar manner to related compounds such as 25I-NBOMe, which is a potent agonist at the 5HT 2A receptor.  25D-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as  25I-NBOMe and 25C-NBOMe. It was banned as a  Temporary Class Drug in the UK on 10 June 2013 after concerns about its recreational use. 
Legal status and scheduling [ edit ]
United States [ edit ]
Unregulated at a federal and state level, though arguably may contravene the
Federal Analog Act under certain circumstances given its structural and functional similarity to controlled substance 2C-D.
added 25D-NBOMe to schedule I ( Sveriges riksdag "substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of Aug 1, 2013, published by in their regulation Medical Products Agency LVFS 2013:15 listed as 25D-NBOMe 2-(2,5-dimetoxi-4-metylfenyl)-N-(2-metoxibensyl)etanamin. 
As of October 2015 25D-NBOMe is a controlled substance in China.
See also [ edit ]
References [ edit ]
^ Hansen, M.; Phonekeo, K.; Paine, J. S.; Leth-Petersen, S.; Begtrup, M.; Bräuner-Osborne, H.; Kristensen, J. L. (2014). "Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT. 2A/2C Agonists" ACS Chemical Neuroscience. 5 (3): 243–9. PMC . 3963123 PMID 24397362. doi: 10.1021/cn400216u.
^ Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.
^ Casale, John F.; Hays, Patrick A. (2012). "Characterization of Eleven 2,5-Dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) Derivatives and Differentiation from their 3- and 4-Methoxybenzyl Analogues - Part I" (PDF). Microgram Journal. 9 (2): 84–109 . Retrieved . 14 January 2014
^ "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 Jun 2013 . Retrieved . 2013-07-10
^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015 . Retrieved . 1 October 2015